SCHEMBL12704658

SCHEMBL12704658

C#C[C@]1(O)CCCC2[C@](C)(C(=O)OC)CCC[C@]21C

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SOD1 P00441 1/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
POLB P06746 1/20 0.39
HSP90AA1 P07900 1/20 0.39
CYP3A4 P08684 2/20 0.35
MAPT P10636 2/20 0.35
ATM Q13315 1/20 0.35
USP2 O75604 1/20 0.35
TP53 P04637 1/20 0.35
MAPK1 P28482 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
POLA1 P09884 2/20 0.35
ALDH1A1 P00352 1/20 0.33
ALOX15 P16050 1/20 0.33
NR1H2 P55055 1/20 0.32
NR1H3 Q13133 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL280136 1.00 SOD1 (0.40) SOD1MEN1KMT2APOLBHSP90AA1
SCHEMBL279974 1.00 SOD1 (0.40) SOD1MEN1KMT2APOLBHSP90AA1
SCHEMBL12872356 1.00 SOD1 (0.40) SOD1MEN1KMT2APOLBHSP90AA1
SCHEMBL280322 1.00 SOD1 (0.40) SOD1MEN1KMT2APOLBHSP90AA1
SCHEMBL267258 0.76 CYP3A4 (0.36) MEN1KMT2ACYP3A4MAPTMAPK1
SCHEMBL280131 0.76 HSP90AA1 (0.41) SOD1MEN1KMT2APOLBHSP90AA1
SCHEMBL12522489 0.76 HSP90AA1 (0.41) SOD1MEN1KMT2APOLBHSP90AA1
SCHEMBL6009568 0.76 HSP90AA1 (0.41) SOD1MEN1KMT2APOLBHSP90AA1
SCHEMBL280269 0.74 MEN1 (0.40) SOD1MEN1KMT2APOLBHSP90AA1
SCHEMBL14401278 0.74 MEN1 (0.43) SOD1MEN1KMT2APOLBHSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2311795-A2 Interleukin-1 and tumor necrosis factor-alpha modulators; syntheses of such modulators and methods of using such modulators Nereus Pharmaceuticals, Inc. (US) 2011-04-20 EP disclosed